Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

IceCure Medical (ICCM) Shares Outstanding (2020 - 2025)

IceCure Medical has reported Shares Outstanding over the past 6 years, most recently at $73.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 29.26% year-over-year to $73.1 million; the TTM value through Dec 2025 reached $73.1 million, up 29.26%, while the annual FY2025 figure was $73.1 million, 29.26% up from the prior year.
  • Shares Outstanding was $73.1 million for Q4 2025 at IceCure Medical, up from $56.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $73.1 million in Q4 2025 and bottomed at $1.0 million in Q4 2021.
  • The 5-year median for Shares Outstanding is $45.7 million (2023), against an average of $44.4 million.
  • Year-over-year, Shares Outstanding surged 19128.34% in 2021 and then rose 0.23% in 2023.
  • Over 5 years, Shares Outstanding stood at $1.0 million in 2021, then soared by 4312.32% to $45.6 million in 2022, then rose by 0.23% to $45.7 million in 2023, then grew by 23.7% to $56.6 million in 2024, then grew by 29.26% to $73.1 million in 2025.
  • The last three reported values for Shares Outstanding were $73.1 million (Q4 2025), $56.6 million (Q4 2024), and $45.7 million (Q4 2023) per Business Quant data.